Humana Inc.
Humana Inc. to Reaffirm FY 2025 Guidance in Upcoming Investor Meetings
Summary
Humana Inc. announced that its senior management team will meet with investors and analysts between September 1, 2025, and September 30, 2025, to reaffirm its guidance for FY 2025. The Company intends to reaffirm its guidance of approximately $13.77 in diluted earnings per common share (EPS) or approximately $17.00 in adjusted earnings per common share (Adjusted EPS). Adjusted EPS is a non-GAAP financial measure that management uses to analyze core operating performance. The Company will not comment on 2026 Medicare Advantage Star Ratings until CMS releases the data in October.
Profitelligence Alerts
Get alerts for HUM
Be first to know when Humana Inc. files with the SEC.
Filing Categories
Advertisement
About Humana Inc.
Humana Inc. is a leading healthcare insurance company that primarily focuses on offering comprehensive health insurance products and services. It operates in the insurance sector and is a significant player in the Medicare Advantage market, providing coverage solutions for senior citizens eligible for Medicare. Additionally, Humana boasts a diverse range of health plans, including individual, group medical plans, and specialty products like dental and vision care. The company extends its services to various sectors, including government-sponsored healthcare programs and commercial employers, emphasizing wellness and preventive care. Humana’s offerings are designed to meet the needs of both individual consumers and large organizations, ensuring tailored healthcare coverage. Based in Louisville, Kentucky, Humana is a crucial component of the healthcare system in the United States, striving to improve health outcomes and provide affordable insurance options. The company continues to influence the healthcare industry by enhancing its digital solutions and fostering partnerships that promote integrated care between medical professionals and insurers.
Official SEC Documents
Advertisement